[Remote] Senior Software QA Engineer II at iRhythm Technologies

United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Medical Devices, Healthcare TechnologyIndustries

Skills

Key technologies and capabilities for this role

QATest PlanningTest ExecutionTest ProtocolsTest ReportsTraceability MatricesFDA ComplianceIEC 62304ISO 13485Risk AssessmentDatabasesAPIsLinuxData IntegritySystem BehaviorWorkflow AccuracyIntegration TestingData PipelinesRoot Cause AnalysisRegression TestingAgileSoftware Development Lifecycle

Questions & Answers

Common questions about this position

What experience level is required for this Senior Software QA Engineer II role?

A Bachelor’s degree in a technical discipline and 10+ years of software QA experience are required, including 3+ years in medical device or FDA-regulated software development.

What key skills are needed for verification and testing in this position?

Candidates need experience leading verification test efforts for medium to large projects, ownership of DHF deliverables like test plans and traceability matrices, and working with databases, APIs, and Linux environments.

Is the salary or compensation specified for this role?

This information is not specified in the job description.

What is the work arrangement or location policy for this position?

This information is not specified in the job description.

What makes a strong candidate for this Senior Software QA Engineer II role?

Strong candidates have 10+ years of QA experience in FDA-regulated environments, proven leadership in verification testing and DHF deliverables, and the ability to mentor juniors while championing quality in Agile teams.

iRhythm Technologies

Advanced cardiac monitoring solutions provider

About iRhythm Technologies

iRhythm Technologies focuses on cardiac monitoring solutions, with its main product being the Zio Patch, a wearable device that tracks heart rhythms for up to 14 days. This extended monitoring helps healthcare providers detect irregular heart rhythms that shorter monitoring might miss, making it especially useful for patients at risk. The company serves both patients and healthcare providers, generating revenue by selling the Zio Patch and offering data analysis services to interpret the collected heart data. iRhythm aims to improve patient outcomes and streamline healthcare workflows in the cardiac health sector.

San Francisco, CaliforniaHeadquarters

2006Year Founded

$102.8MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

1,001-5,000Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Paid Vacation

Paid Holidays

401(k) Retirement Plan

401(k) Company Match

Employee Stock Purchase Plan

Mental Health Support

Hybrid Work Options

Pet Insurance

Risks

Increased competition from emerging cardiac monitoring technologies threatens market share.

FDA warning letter may lead to regulatory scrutiny and potential fines.

Shareholder investigation could result in legal challenges and financial liabilities.

Differentiation

Zio Patch offers up to 14 days of uninterrupted cardiac monitoring.

iRhythm's Zio Patch is the smallest and least conspicuous cardiac diagnostic device.

The company provides data analysis services for actionable insights from Zio Patch data.

Upsides

Wearable health tech market growth aligns with iRhythm's business model.

Telehealth expansion increases demand for remote monitoring solutions like Zio Patch.

AI integration enhances arrhythmia detection accuracy in iRhythm's Zio Patch.

Land your dream remote job 3x faster with AI

Try Jobo Free